Whitepapers/App Notes/Posters

Application note: The Monocyte Activation Assay: The benefits of an animal-free test to show pyrogen-free pharmaceutical products

Posted: 29 June 2021 | | No comments yet

Fever is something that most of us have experienced. However, when we use medicines or medical devices, we expect them to improve our health – not to cause a fever.

One of the culprits of fevers is the presence of pyrogens. Pyrogens are fever inducing substances that at a low dose may induce influenza-like symptoms. Exposure to high doses of these substances can even result in multiple organ failure or even death. Pyrogenic responses may be material-mediated, endotoxin-mediated, or mediated by other substances such as components of Gram-positive bacteria and fungi. Therefore, parenteral pharmaceuticals and medical devices that come into contact with the blood stream or cerebrospinal fluids should be free of pyrogens (EP 2.6.8, USP <151>, ISO 10993-11).












    To read this application note in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Nelson Labs

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Related organisations

    Send this to a friend